Naperville, IL -- (ReleaseWire) -- 11/01/2012 -- Healthcare, Regulatory and Reimbursement Landscape - Canada report is an essential source of information and an analysis on the healthcare, regulatory, and reimbursement landscape of Canada. The report identifies the key trends in the Canadian healthcare market, and also provides insights on the demographic, regulatory, and reimbursement landscape, as well as the healthcare infrastructure. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices markets. This report was developed using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Canada’s population was approximately 34.4 million in 2011, and is growing largely as a result of immigration. The natural growth rate of the population is projected to be low due to the balance between the mortality and birth rates. The increasing elderly population, however, is a matter of concern for policy planners.
The pharmaceutical market in Canada was valued at about $21.5 billion in 2010 and is expected to reach approximately $45.9 billion by 2020, at a projected 9.9% CAGR. The medical device market was valued at approximately $7.7 billion in 2011 and is expected to reach approximately $12.2 billion by 2020, at a projected 5.2% CAGR.
The positive trend in the Canadian healthcare market can be attributed primarily to -
- Increasing elderly population
- Universal healthcare coverage
- High degree of access to healthcare facilities
- Government initiatives for the prevention and management of chronic diseases
- Strong, efficient, and transparent guidelines that simplify the regulatory process
The report provides information on the healthcare, regulatory, and reimbursement landscape of Canada. The scope includes -
- Overview of the pharmaceutical and medical devices market of Canada including the market size, market segmentation, and key drivers and barriers for the market.
- Profile and SWOT analysis of the major players in the pharmaceutical and medical devices markets. Key players covered for the pharmaceutical market are Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Apotex. Key players covered for the medical devices market are Medtronic, Siemens Healthcare, Essilor International, GlaxoSmithKline, and Zimmer Holdings.
- Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and market authorization process for new drug and medical devices for Canada.
- A detailed analysis of the political and economic environment of Canada, including key economic indicators, demographics, healthcare infrastructure and healthcare expenditures.
- An overview of the opportunities and challenges for growth in the Canadian healthcare market.
Reasons to buy
This report provides comprehensive coverage of both the pharmaceutical and the medical devices markets in Canada. It will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Canadian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments, and companies likely to impact the market in future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in the healthcare market of Canada
To view table of contents for this market report please visit: